Cancer Research UK logo.
SearchDonate
  • Search
Health professionals

The CAM and CAM+ archive

The Cancer Awareness Measure ‘Plus’ (CAM+) is a survey that regularly collects nationally representative data about the UK public’s attitudes, awareness and behaviours across key early diagnosis, screening and prevention topics.

This page contains all past CAM and CAM+ surveys, reports and publications, and tells you whether you can translate and adapt the surveys.

Download the 2024 findingsDownload the latest survey

Please Note: The CAM+ findings for the UK and the devolved nations have been made available in PowerPoint format so that the slide notes can be used to support interpretation of the results. Please do not edit any aspect of these files.

Past CAM and CAM+ surveys

You don’t need to request permission to download and use past CAM and CAM+ surveys or other cancer specific versions of the measure. However, none of the cancer-specific CAM surveys have been updated in line with any developments in the evidence or changes to clinical practice, so please review and consider whether the survey is still appropriate. Further, the CAM+ surveys have not been validated.

Read the questions included in each of the generic CAM surveys (2008-2023)

Past generic CAM and CAM+ surveys

CAM+ 2024(PDF, 505 KB)

CAM+ September 2023(PDF, 1.23 MB)

CAM+ February 2023(PDF, 1.15 MB)

CAM+ September 2022(PDF, 1.17 MB)

CAM+ February 2022(PDF, 699 KB)

CAM+ September 2021(PDF, 643 KB)

COVID-CAM+ February/March 2021(PDF, 658 KB)

COVID-CAM+ August/September 2020(PDF, 648 KB)

CAM+ 2019(PDF, 1.19 MB)

CAM+ 2017 – ONS Survey(PDF, 263 KB)

CAM+ 2017 – NatCen Panel Survey(PDF, 256 KB)

CAM+ 2017 – YouGov Panel Survey(PDF, 140 KB)

CAM+ 2014(PDF, 52.9 KB)

CAM 2012(PDF, 139 KB)

CAM 2010(PDF, 138 KB)

CAM 2008 toolkit(PDF, 1.87 MB)

Past cancer specific CAM surveys

Bowel CAM toolkit(PDF, 1.78 MB)

Breast CAM toolkit(PDF, 2.02 MB)

Cervical CAM toolkit(PDF, 1.82 MB)

Lung CAM toolkit(PDF, 1.75 MB)

Ovarian CAM toolkit(PDF, 1.79 MB)

Frequently asked questions

Translation

Cancer Research UK, in association with academic partners and other cancer charities, developed and validated the original generic Cancer Awareness Measure, and measures for breast, cervical, colorectal/bowel, ovarian and lung cancer. These measures have been written and validated in English. If you would like to translate any of the CAM surveys into a different language, please note the following:

  • We encourage translation of the measures using appropriate methods (such as forward and back translation) and strongly advise that any translated versions are subsequently validated to ensure that the measure is reliable and valid.

  • You do not need Cancer Research UK’s permission to translate any of the CAM surveys, however, translated versions should not use the Cancer Research UK logo and should carry the notice provided.

Find out which notice to use for your translated survey(PDF, 69.6 KB)

Adaptation

It is possible to make the following changes or adaptations to the CAM and CAM+ surveys:

  • You can change the order of the CAM and CAM+ modules.

  • There is one exception to this; closed or prompted questions should always be asked after open or unprompted questions. For example, the closed question ‘The following may or may not be warning signs for cancer. We are interested in your opinion’, should be asked before the open question ‘There are many warning signs and symptoms of cancer. Please name as many as you can think of’. This is because the closed/prompted questions essentially provide the answers to the open/unprompted questions.

  • You can change the ordering of items within modules. You may wish to counterbalance or rotate the order to see if this has any affect on people’s responses.

  • You can ask additional questions alongside the CAM and CAM+ questions.

  • For example, if you’re using the CAM/CAM+ to assess the impact of an intervention you will want to ask some more specific questions about the intervention itself. In doing so, you should consider how these questions could affect the respondent’s response to the CAM/CAM+. For example, you should avoid asking questions that could increase the participant’s knowledge about cancer.

  • You can remove questions that are not necessary or appropriate, but we recommend you don’t remove items within a question e.g. a specific barrier from the barriers question.

  • You may adapt questions to better suit your target audience e.g. where a survey refers to the NHS you may want to replace this with the name of the appropriate health service. Where changes are made to questions, we recommend that you validate the survey to ensure it is reliable and valid.

Past reports and publications

Whitelock, V., (2024) Cancer Research UK’s 2024 Cancer Awareness Measure ‘Plus’ (CAM+)

Whitelock, V., Hirst, A., Harrison, S., (2024). Cancer Awareness Measure ‘Plus’ (CAM+) Spotlight Report: Scotland(PDF, 909 KB).

Whitelock, V., (2023). Cancer Research UK’s September 2023 Cancer Awareness Measure ‘Plus’ (CAM+)(PDF, 690 KB).

Rennie, D., (2023) Cancer Research UK’s February 2023 Cancer Awareness Measure ‘Plus’ (CAM+)(PDF, 1.03 MB).

Lifford et al., (2023). Satisfaction with remote consultations in primary care during COVID-19: a population survey of UK adults.

Tungwarara, N., (2022). Cancer Research UK’s September 2022 Cancer Awareness Measure ‘Plus’ (CAM+)(PDF, 1.33 MB).

Whitelock, V., Tungwarara, N., (2022). Cancer Research UK’s February 2022 Cancer Awareness Measure ‘Plus’(PDF, 1.3 MB).

Anyanwu et al., (2022). Health behaviour change among UK adults during the pandemic.

Whitelock, V., (2021). Cancer Research UK’s September 2021 Cancer Awareness Measure ‘Plus’ (CAM+)(PDF, 1.14 MB).

Wilson et al., (2021). Intentions to participate in cervical and colorectal cancer screening during the COVID-19 pandemic: A mixed-methods study.

Quinn-Scoggins et al., (2021). Cancer symptom experience and help-seeking behaviour during the COVID-19 pandemic in the UK: a cross-sectional population survey.

CABS study team (2021). Cancer symptom experience and help-seeking behaviour in the UK adult population during the COVID-19 pandemic(PDF, 516 KB).

Cancer Research UK and Cardiff University (June 2021). Cancer symptom experience and help-seeking behaviours in Northern Ireland, Wales, England and Scotland during the COVID-19 pandemic: Results from the COVID Health and Help-Seeking Behaviour Study and Cancer Research UK’s COVID Cancer Awareness Measure (COVID-CAM)(PDF, 290 KB).

CABS study team (2021). Cervical and colorectal cancer screening during COVID-19(PDF, 200 KB).

Connor et al., (2020). Awareness of the Signs, Symptoms, and Risk Factors of Cancer and the Barriers to Seeking Help in the UK: Comparison of Survey Data Collected Online and Face-to-Face.

Crawford, C., (2019). Cancer Research UK’s 2019 Cancer Awareness Measure ‘Plus’ (CAM+)(PPTX, 8.22 MB).

Connor, K., Hudson, B., Osborne, K & Power, E (2019). Comparing data collected online and face to face. Cancer Intelligence. Cancer Research UK(PDF, 519 KB).

Moffat et al., (2016). Identifying anticipated barriers to help-seeking to promote earlier diagnosis of cancer in Great Britain.

Cancer Research UK (2014). Cancer Awareness Measure (CAM) Key Findings Report; 2014 & Trends Analysis (2008-2014)(PDF, 1.03 MB).

Simon et al., (2012). Knowledge of lung cancer symptoms and risk factors in the U.K.: development of a measure and results from a population-based survey.

Simon et al., (2012). Ovarian and cervical cancer awareness: development of two validated measurement tools.

Power et al., (2011). Assessing awareness of colorectal cancer symptoms: Measure development and results from a population survey in the UK.

Linsell et al., (2010). Validation of a measurement tool to assess awareness of breast cancer.

Stubbings et al., (2009). Development of a measurement tool to assess public awareness of cancer.

Contact us

Dr Vicky Whitelock is a Health Research and Evaluation Manager and leads the Cancer Awareness Measure ‘Plus’ portfolio of work.

Email Vicky